Re: CYP2D6 genotyping and the use of tamoxifen in breast cancer
- PMID: 24408655
- PMCID: PMC4067108
- DOI: 10.1093/jnci/djt379
Re: CYP2D6 genotyping and the use of tamoxifen in breast cancer
Comment in
-
Response.J Natl Cancer Inst. 2014 Feb;106(2):djt380. doi: 10.1093/jnci/djt380. Epub 2014 Jan 9. J Natl Cancer Inst. 2014. PMID: 24408654 No abstract available.
Comment on
-
CYP2D6 genotyping and the use of tamoxifen in breast cancer.J Natl Cancer Inst. 2013 Sep 4;105(17):1267-9. doi: 10.1093/jnci/djt221. Epub 2013 Aug 19. J Natl Cancer Inst. 2013. PMID: 23958737 No abstract available.
References
-
- Berry D. CYP2D6 genotyping and the use of tamoxifen in breast cancer. J Natl Cancer Inst. 2013;105(17):1267–1269 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical